Terms: = Leukemia AND CLTC, CLTCL2, 1213, ENSG00000141367, Q00610 AND Treatment
26 results:
1. [Analysis of the clinical characteristics of acute myeloid leukemia related to the treatment of hematological and solid tumors].
Jiao Y; Jiang YH; Liu B; Mi RH; Bi LJ; Xu QX
Zhonghua Zhong Liu Za Zhi; 2024 Jan; 46(1):86-95. PubMed ID: 38246784
[No Abstract] [Full Text] [Related]
2. Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic leukemia Relapsing after First-Line treatment with Fixed-Duration Ibrutinib plus Venetoclax.
Jain N; Croner LJ; Allan JN; Siddiqi T; Tedeschi A; Badoux XC; Eckert K; Cheung LWK; Mukherjee A; Dean JP; Szafer-Glusman E; Seymour JF
Clin Cancer Res; 2024 Feb; 30(3):498-505. PubMed ID: 37955424
[TBL] [Abstract] [Full Text] [Related]
3. Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML.
Tsai XC; Sun KJ; Lo MY; Tien FM; Kuo YY; Tseng MH; Peng YL; Chuang YK; Ko BS; Tang JL; Sun HI; Liu MC; Liu CW; Lin CC; Yao M; Chou WC; Hou HA; Tien HF
Blood Cancer J; 2023 Jan; 13(1):4. PubMed ID: 36599822
[TBL] [Abstract] [Full Text] [Related]
4. Prospective longitudinal evaluation of treatment-related toxicity and health-related quality of life during the first year of treatment for pediatric acute lymphoblastic leukemia.
Schilstra CE; McCleary K; Fardell JE; Donoghoe MW; McCormack E; Kotecha RS; Lourenco RA; Ramachandran S; Cockcroft R; Conyers R; Cross S; Dalla-Pozza L; Downie P; Revesz T; Osborn M; Alvaro F; Wakefield CE; Marshall GM; Mateos MK; Trahair TN
BMC Cancer; 2022 Sep; 22(1):985. PubMed ID: 36109702
[TBL] [Abstract] [Full Text] [Related]
5. Isolated anemia in patients with large granular lymphocytic leukemia (LGLL).
Salama Y; Zhao F; Oliveira JL; Yuan J; Jevremovic D; Go RS; Ding W; Parikh SA; Shah MV; Hampel PJ; Al-Kali A; Morice WG; Shi M
Blood Cancer J; 2022 Feb; 12(2):30. PubMed ID: 35194022
[TBL] [Abstract] [Full Text] [Related]
6. A causal inference approach to compare leukaemia treatment outcome in the absence of randomization and with dependent censoring.
Bernasconi DP; Antolini L; Rossi E; Blanco-Lopez JG; Galimberti S; Andersen PK; Valsecchi MG
Int J Epidemiol; 2022 Feb; 51(1):314-323. PubMed ID: 34368848
[TBL] [Abstract] [Full Text] [Related]
7. Chemical constituents of Patrinia heterophylla Bunge and selective cytotoxicity against six human tumor cells.
Sheng L; Yang Y; Zhang Y; Li N
J Ethnopharmacol; 2019 May; 236():129-135. PubMed ID: 30853646
[TBL] [Abstract] [Full Text] [Related]
8. Imatinib in myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phase.
Jawhar M; Naumann N; Schwaab J; Baurmann H; Casper J; Dang TA; Dietze L; Döhner K; Hänel A; Lathan B; Link H; Lotfi S; Maywald O; Mielke S; Müller L; Platzbecker U; Prümmer O; Thomssen H; Töpelt K; Panse J; Vieler T; Hofmann WK; Haferlach T; Haferlach C; Fabarius A; Hochhaus A; Cross NCP; Reiter A; Metzgeroth G
Ann Hematol; 2017 Sep; 96(9):1463-1470. PubMed ID: 28725989
[TBL] [Abstract] [Full Text] [Related]
9. [A clinical study of fungal esophagitis in 13 patients with hematologic malignancies].
Zhou YL; Wei XD; Mi RH; Ai H; Zhang LN; Liu YY; Li YF; Song YP
Zhonghua Xue Ye Xue Za Zhi; 2016 Jun; 37(6):507-11. PubMed ID: 27431077
[TBL] [Abstract] [Full Text] [Related]
10. The clinical significance of negative flow cytometry immunophenotypic results in a morphologically scored positive bone marrow in patients following treatment for acute myeloid leukemia.
Ouyang J; Goswami M; Tang G; Peng J; Ravandi F; Daver N; Routbort M; Konoplev S; Lin P; Medeiros LJ; Jorgensen JL; Wang SA
Am J Hematol; 2015 Jun; 90(6):504-10. PubMed ID: 25732229
[TBL] [Abstract] [Full Text] [Related]
11. Tetrandrine citrate eliminates imatinib-resistant chronic myeloid leukemia cells in vitro and in vivo by inhibiting Bcr-Abl/β-catenin axis.
Xu XH; Gan YC; Xu GB; Chen T; Zhou H; Tang JF; Gu Y; Xu F; Xie YY; Zhao XY; Xu RZ
J Zhejiang Univ Sci B; 2012 Nov; 13(11):867-74. PubMed ID: 23125079
[TBL] [Abstract] [Full Text] [Related]
12. Neurotoxic factors released by stimulated human monocytes and THP-1 cells.
Lee M; Suk K; Kang Y; McGeer E; McGeer PL
Brain Res; 2011 Jul; 1400():99-111. PubMed ID: 21640980
[TBL] [Abstract] [Full Text] [Related]
13. Dic(17;18)(p11.2;p11.2) is a recurring abnormality in chronic lymphocytic leukaemia associated with aggressive disease.
Woyach JA; Heerema NA; Zhao J; McFaddin A; Stark A; Lin TS; Andritsos LA; Blum KA; Flynn JM; Jones JA; Byrd JC
Br J Haematol; 2010 Mar; 148(5):754-9. PubMed ID: 20015097
[TBL] [Abstract] [Full Text] [Related]
14. Assessment of chosen parameters of the immune system in children with acute lymphoblastic leukemia.
Mazur B; Olejnik I; Wylezol I; Sonta-Jakimczyk D; Szczepanski T; Karpe J
Pediatr Hematol Oncol; 2003 Jun; 20(4):303-8. PubMed ID: 12746162
[TBL] [Abstract] [Full Text] [Related]
15. Mucormycosis in hematologic malignancies: an emerging fungal infection.
Nosari A; Oreste P; Montillo M; Carrafiello G; Draisci M; Muti G; Molteni A; Morra E
Haematologica; 2000 Oct; 85(10):1068-71. PubMed ID: 11025599
[TBL] [Abstract] [Full Text] [Related]
16. 131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients.
Garaventa A; Bellagamba O; Lo Piccolo MS; Milanaccio C; Lanino E; Bertolazzi L; Villavecchia GP; Cabria M; Scopinaro G; Claudiani F; De Bernardi B
Br J Cancer; 1999 Dec; 81(8):1378-84. PubMed ID: 10604736
[TBL] [Abstract] [Full Text] [Related]
17. Fludarabine-containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukaemia patients.
Visani G; Lemoli RM; Tosi P; Martinelli G; Testoni N; Ricci P; Piccaluga PP; Pastano R; Leopardi G; Dizdari A; Motta MR; Rizzi S; Tura S
Br J Haematol; 1999 Jun; 105(3):775-9. PubMed ID: 10354146
[TBL] [Abstract] [Full Text] [Related]
18. Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow.
Zander AR; Zabelina T; Kröger N; Renges H; Krüger W; Löliger C; Dürken M; Stockschläder M; de Wit M; Wacker-Backhaus G; Bielack S; Jaburg N; Rüssmann B; Erttmann R; Kabisch H
Bone Marrow Transplant; 1999 May; 23(9):889-93. PubMed ID: 10338043
[TBL] [Abstract] [Full Text] [Related]
19. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
Grumbach MM; Bin-Abbas BS; Kaplan SL
Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
[TBL] [Abstract] [Full Text] [Related]
20. Application of fluorescence microscopy to measure apoptosis in Jurkat T cells after treatment with a new investigational anticancer agent (N.C.1213).
Vashishtha SC; Nazarali AJ; Dimmock JR
Cell Mol Neurobiol; 1998 Aug; 18(4):437-45. PubMed ID: 9619299
[TBL] [Abstract] [Full Text] [Related]
[Next]
